deficit de hierro

¿Es usted
profesional sanitario?

No

Está usted accediendo a la página web “Déficit de Hierro”, dirigida a difundir información médica y promover la formación sobre los estados carenciales de hierro y la anemia ferropénica.

La información contenida en esta página está destinada exclusivamente a profesionales sanitarios con capacidad para prescribir o dispensar medicamentos, por lo que se requiere una formación especializada para su correcta interpretación. Si Vd. no es profesional sanitario cualificado, Zambon no se hace responsable de los perjuicios que pueda sufrir por las decisiones basadas en el contenido de esta página o de cualquiera de sus enlaces.

+

Selección bibliográfica de artículos


Semestralmente se realiza una actualización de la revisión bibliográfica según los criterios establecidos.

La selección actual de artículos corresponde a material publicado desde enero de 2013 hasta febrero de 2017.

Los usuarios pueden solicitar a la Secretaría Científica el envío vía e-mail de aquellos artículos que sean de su interés.


Cardiología

  • Targeting Iron Deficiency Anemia in Heart Failure.
    Saraon T, Katz SD.
    Prog Cardiovasc Dis. 2016 Jan-Feb;58(4):407-15. doi: 10.1016/j.pcad.2015.11.007. Epub 2015 Dec 2.

  • Effects of Iron Supplementation With and Without Docosahexaenoic Acid on the Cardiovascular Disease Risk Based on Paraoxonase-1, hs-CRP, and ApoB/ApoA-I Ratio in Women with Iron Deficiency Anemia.
    Shidfar F, Amani S, Vafa M, Shekarriz R, Hosseini S, Shidfar S, Eshraghian M, Mousavi SN.
    Biol Trace Elem Res. 2016 Jan;169(1):34-40. doi: 10.1007/s12011-015-0383-7. Epub 2015 Jun 17.

  • Targeting iron deficency anaemia in heart failure
    Saraon T, Katz SD.
    Prog Cardiovasc Dis. 2015 Dec 1. pii: S0033-0620(15)30026-8. doi: 10.1016/j.pcad.2015.11.007.

  • Recurrent Acute Decompensated Heart Failure Owing to Severe Iron Deficiency Anemia Caused by Inappropriate Habitual Bloodletting.
    Lim WH, Kim SH, Kim HL, Kim KH, Na SH, Lee HJ, Kang EG, Seo JB, Chung WY, Zo JH, Hong JA, Kim K, Kim MA.
    J Cardiovasc Ultrasound. 2015 Dec;23(4):253-6. doi: 10.4250/jcu.2015.23.4.253. Epub 2015 Dec 30.

  • Strain and Worse in Acute Dilated Cardiomyopathy Pediatric Patients with Poor Outcomes at One Year.
    Webb MK, Auerbach SR, Younoszai AK, Patel SS, Landeck BF 2nd.
    Echocardiography. 2015 Nov;32(11):1688-96. doi: 10.1111/echo.12947.

  • Heart failure and pulmonary arteriovenous malformations in a patient with hereditary hemorrhagic telangiectasia type 2
    Du J, Zhu Y, Zhang YL, Li S, Huang J, Luo XH, Liu L.
    J Thromb Thrombolysis. 2015 Nov;40(4):515-9. doi: 10.1007/s11239-015-1253-z

  • Prevalent cardiac, renal and cardiorenal damage in patients with advanced abdominal aortic aneurysms.
    Barisione C, Garibaldi S, Brunelli C, Balbi M, Spallarossa P, Canepa M, Ameri P, Viazzi F, Verzola D, Lorenzoni A, Baldassini R, Palombo D, Pane B, Spinella G, Ghigliotti G.
    Intern Emerg Med. 2015 Oct 28.

  • Iron deficiency and hemolytic anemia reversed by ventricular septal myectomy.
    Thotakura S, Costa SM, Cable C.
    Proc (Bayl Univ Med Cent). 2015 Oct;28(4):494-5. PubMed PMID: 26424952; PubMed Central PMCID: PMC4569235.

  • A Cost-effectiveness Analysis of Ferric Carboxymaltose in Patients With Iron Deficiency and Chronic Heart Failure in Spain.
    Comín-Colet J, Rubio-Rodríguez D, Rubio-Terrés C, Enjuanes-Grau C, Gutzwiller FS, Anker SD, Ponikowski P.
    Rev Esp Cardiol (Engl Ed). 2015 Oct;68(10):846-51. doi: 10.1016/j.rec.2014.10.010.

  • Effect of Correction of Anemia on Echocardiographic and Clinical Parameters in Patients With Aortic Stenosis Involving a Three-Cuspid Aortic Valve and Normal Left Ventricular Ejection Fraction.
    Gómez M, Ble M, Cladellas M, Molina L, Comín-Colet J, Enjuanes C, Roqueta C, Soler C, Bruguera J.
    Am J Cardiol. 2015 Jul 15;116(2):270-4. doi: 10.1016/j.amjcard.2015.04.020.

  • Clinical use of low haemoglobin density, transferrin saturation, bone marrow morphology, Perl's stain and other plasma markers in the identification of treatable anaemia presenting for cardiac surgery in a prospective cohort study.
    Martin-Cabrera P, Hung M, Ortmann E, Richards T, Ghosh M, Bottrill F, Collier T, Klein AA, Besser MW.
    J Clin Pathol. 2015 Jul 1. pii: jclinpath-2015-203024. doi: 10.1136/jclinpath-2015-203024.

  • Effects of Iron Supplementation With and Without Docosahexaenoic Acid on the Cardiovascular Disease Risk Based on Paraoxonase-1, hs-CRP, and ApoB/ApoA-I Ratio in Women with Iron Deficiency Anemia.
    Farzad Shidfar, Samira Amani, Mohammadreza Vafa, Ramin Shekarriz, Sharieh Hosseini, Shahrzad Shidfar, Mohammadreza Eshraghian, Seyedeh Neda Mousavi
    Biol Trace Elem Res. DOI: 10.1007/s12011-015-0383-7

  • Repletion of Iron Stores With the Use of Oral Iron Supplementation in Patients With Systolic Heart Failure
    Niehaus ED, Malhotra R, Cocca-Spofford D, Semigran M, Lewis GD
    J Card Fail. 2015 May 29. pii: S1071-9164(15)00155-4.

  • Cardiovascular outcomes of intravenous iron in perspective of clinical trials and the use of different iron preparations
    Toblli JE, Cao G, Angerosa M.
    Int J Cardiol. 2015 May 6;187:196-7. doi: 10.1016/j.ijcard.2015.03.327.

  • TIDILAP: Treatment of iron deficiency in lipoprotein apheresis patients - A prospective observational multi-center cohort study comparing efficacy, safety and tolerability of ferric gluconate with ferric carboxymaltose.
    Schatz U, Illigens BM, Siepmann T, Arneth B, Siegert G, Siegels D, Heigl F, Hettich R, Ramlow W, Prophet H1, Bornstein SR, Julius U.
    Atheroscler Suppl. 2015 May;18:199-208. doi: 10.1016/j.atherosclerosissup.2015.02.030.

  • Parameters influencing in-hospital mortality in patients hospitalized in intensive cardiac care unit: is there an influence of anemia and iron deficiency?
    Uscinska E1, Sobkowicz B, Sawicki R, Kiluk I, Baranicz M, Stepek T, Dabrowska M, Szmitkowski M, Musial WJ, Tycinska AM.
    Intern Emerg Med. 2015 Apr;10(3):337-44. doi: 10.1007/s11739-014-1170-8.

  • Is anemia a new cardiovascular risk factor?.
    Kaiafa G, Kanellos I, Savopoulos C, Kakaletsis N, Giannakoulas G, Hatzitolios AI.
    Int J Cardiol. 2015 Mar 17;186:117-124. doi: 10.1016/j.ijcard.2015.03.159. [Epub ahead of print].

  • Cardiac remodeling in response to chronic iron deficiency: role of the erythropoietin receptor.
    Naito Y, Sawada H, Oboshi M, Iwasaku T, Okuhara Y, Morisawa D, Eguchi A, Hirotani S, Mano T, Tsujino T, Masuyama T.
    J Hypertens. 2015 Feb 24. [Epub ahead of print].

  • Changes in Echocardiographic Parameters in Iron Deficiency Patients with Heart Failure and Chronic Kidney Disease Treated with Intravenous Iron.
    Toblli JE, Di Gennaro F, Rivas C.
    Heart Lung Circ. 2015 Jan 21. pii: S1443-9506(15)00034-7. doi: 10.1016/j.hlc.2014.12.161. [Epub ahead of print].

  • A Cost-effectiveness Analysis of Ferric Carboxymaltose in Patients With Iron Deficiency and Chronic Heart Failure in Spain.
    Comín-Colet J, Rubio-Rodríguez D, Rubio-Terrés C, Enjuanes-Grau C, Gutzwiller FS, Anker SD, Ponikowski P.
    Rev Esp Cardiol (Engl Ed). 2015 Jan 28. pii: S1885-5857(14)00462-9. doi: 10.1016/j.rec.2014.10.010. [Epub ahead of print].

  • Heart failure and iron deficiency anaemia: a complex dance.
    Callender T, Rahimi K.
    Heart. 2015 Jan 30. pii: heartjnl-2014-307227. doi: 10.1136/heartjnl-2014-307227. [Epub ahead of print].

  • Effects of an accelerated intravenous iron regimen in hospitalized patients with advanced heart failure and iron deficiency.
    Reed BN, Blair EA, Thudium EM, Waters SB, Sueta CA, Jensen BC, Rodgers JE.
    Pharmacotherapy. 2015 Jan;35(1):64-71. doi: 10.1002/phar.1525. Epub 2014 Dec 29.

  • Liver Congestion in Heart Failure Contributes to Inappropriately Increased Serum Hepcidin despite Anemia.
    Ohno Y, Hanawa H, Jiao S, Hayashi Y, Yoshida K, Suzuki T, Kashimura T, Obata H, Tanaka K, Watanabe T, Minamino T.
    Tohoku J Exp Med. 2015;235(1):69-79. doi: 10.1620/tjem.235.69.

  • A prospective observational cohort study to identify the causes of anaemia and association with outcome in cardiac surgical patients.
    Hung M, Ortmann E, Besser M, Martin-Cabrera P, Richards T, Ghosh M1, Bottrill F, Collier T, Klein AA.
    Heart. 2015 Jan;101(2):107-12. doi: 10.1136/heartjnl-2014-305856. Epub 2014 Sep 12.

  • Iron deficiency: an emerging therapeutic target in heart failure.
    Cohen-Solal A, Leclercq C, Deray G, Lasocki S, Zambrowski JJ, Mebazaa A, de Groote P, Damy T, Galinier M.
    Heart. 2014 Sep 15;100(18):1414-20. doi: 10.1136/heartjnl-2014-305669. Epub 2014 Jun 23.

  • Distinguishing anemia and iron deficiency of heart failure: signal for severity of disease or unmet therapeutic need?
    Beavers CJ, et al.
    Pharmacotherapy, 2014; 34 (7): 719-732.

  • Iron deficiency status irrespective of anemia: a predictor of unfavorable outcome in chronic heart failure patients.
    Rangel I, et al.
    Cardiology, 2014; 128(4):320-6. doi: 10.1159/000358377. Epub 2014 Jun 7.

  • Association of renal tubular damage with cardio-renal anemia syndrome in patients with heart failure.
    Otaki Y, et al.
    Int J Cardiol., 2014; 173 (2): 222-228.

  • Variation in the incidence of hospital-acquired anemia during hospitalization with acute myocardial infarction (data from 57 US hospitals).
    Salisbury AC, Reid KJ, Amin AP, Spertus JA, Kosiborod M.
    Am J Cardiol. 2014 Apr 1;113(7):1130-6. doi: 10.1016/j.amjcard.2013.12.017. Epub 2014 Jan 14.

  • Anemia and iron deficiency in heart failure.
    Arora NP, et al.
    Heart Fail Clin, 2014; apr: 10 (2): 281-294.

  • Inappropriate expression of hepcidin by liver congestion contributes to anemia and relative iron deficiency.
    Suzuki T, et al.
    J Card Fail, 2014; 20 (4): 268-277.

  • Low prevalence of cardiac siderosis in heavily iron loaded Egyptian thalassemia major patients.
    El Beshlawy A, El Tagui M, Hamdy M, El Ghamrawy M, Azim KA, Salem D, Said F, Samir A, St Pierre T, Pennell DJ.
    Ann Hematol. 2014 Mar;93(3):375-9. doi: 10.1007/s00277-013-1876-0. Epub 2013 Aug 15.

  • Aortic valve replacement in a patient with pancytopenia secondary to myelodysplastic syndrome.
    Gangwani AL, Hamid M, Naz F.
    J Pak Med Assoc. 2014 Feb;64(2):207-9.

  • The Role of Treatment for Anemia as a Therapeutic Target in the Management of Chronic Heart Failure: Insights After RED-HF.
    Gaggin HK, Dec GW.
    Curr Treat Options Cardiovasc Med. 2014 Jan;16(1):279. doi: 10.1007/s11936-013-0279-9.

  • Preoperative Anemia Is an Independent Predictor of Postoperative Mortality and Adverse Cardiac Events in Elderly Patients Undergoing Vascular Surgery.
    Xue FS, Cheng Y, Li RP.
    Ann Surg. 2013 Dec 23.

  • Treatment of anemia in patients with heart disease: a clinical practice guideline from the American College of Physicians.
    Qaseem A, Humphrey LL, Fitterman N, Starkey M, Shekelle P; Clinical Guidelines Committee of the American College of Physicians.
    Ann Intern Med.2013 Dec 3;159(11):770-9. doi: 10.7326/0003-4819-159-11-201312030-00009.

  • Treatment of anemia in patients with heart disease: a systematic review
    Kansagara D, Dyer E, Englander H, Fu R, Freeman M, Kagen D.
    Ann Intern Med.2013 Dec 3;159(11):746-57. doi: 10.7326/0003-4819-159-11-201312030-00007.

  • Treatment of anemia in patients with heart disease: a systematic review.
    Kansagara D, Dyer E, Englander H, Fu R, Freeman M, Kagen D.
    Ann Intern Med. 2013 Dec 3;159(11):746-57. doi: 10.7326/0003-4819-159-11-201312030-00007.

  • The Unusual Suspect: Anemia-induced Systolic Anterior Motion of the Mitral Valve and Intraventricular Dynamic Obstruction in a Hyperdynamic Heart as Unexpected Causes of Exertional Dyspnea after Cardiac Surgery.
    Mun JB, Oh AR, Park HS, Park CH, Park KY, Moon J.
    Korean J Thorac Cardiovasc Surg. 2013 Dec;46(6):457-60. doi: 10.5090/kjtcs.2013.46.6.457.

  • Prevalence, factors associated with, and prognostic effects of preoperative anemia on short- and long-term mortality in patients undergoing transcatheter aortic valve implantation.
    Nuis RJ, Sinning JM, Rodés-Cabau J, Gotzmann M, van Garsse L, Kefer J, Bosmans J, Yong G, Dager AE, Revilla-Orodea A, Urena M, Nickenig G, Werner N, Maessen J, Astarci P, Perez S, Benitez LM, Amat-Santos IJ, López J, Dumont E, van Mieghem N, van Gelder T.
    Circ Cardiovasc Interv. 2013 Dec 1;6(6):625-34. doi: 10.1161/CIRCINTERVENTIONS.113.000409.

  • Red Blood Cell Distribution Width Is Longitudinally Associated With Mortality and Anemia in Heart Failure Patients.
    Núñez J, Núñez E, Rizopoulos D, Miñana G, Bodí V, Bondanza L, Husser O, Merlos P, Santas E, Pascual-Figal D, Chorro FJ, Sanchis J.
    Circ J. 2013 Nov 29.

  • Iron deficiency as a good potential prediction of chronic heart failure.
    Shi KH, Tao H, Wu JX.
    Am Heart J. 2013 Oct;166(4):e31. doi: 10.1016/j.ahj.2013.08.002.

  • Iron deficiency in chronic heart failure: an international pooled analysis.
    Klip IT, Et al.
    Am Heart J. 2013 Apr;165(4):575-582.

  • Iron deficiency anemia in infants: does it really affect the myocardial functions?
    Alioglu B, Cetin II, Emeksiz ZS, Dindar N, Tapci E, Dallar Y.
    Pediatr Hematol Oncol.2013 Apr;30(3):239-45. doi: 10.3109/08880018.2012.763077.

  • Anemia associated with chronic heart failure: current concepts.
    Shah R, et al.
    Clin Interv Aging, 2013; 8: 111-122.

Deje su comentario:
Entre en su área de usuario para comentar.
No hay comentarios.